Internal: Archive

Swiss online retailers increasingly hit by fraudsters

This content was published on Oct 24, 2018 A survey of online retailers has shown that losses due to customer fraud are growing – though most scams involve small amounts.

Rhine Falls water level at historic low

This content was published on Oct 24, 2018 The historically hot and dry summer and autumn weather is having a dramatic impact on water levels - such as of the Rhine Falls.

Símbolo de risco biológico sobre o vidro em um laboratório de pesquisas

Swiss-Brazilian disease research faces uncertain future

This content was published on Oct 24, 2018 Scientists are working to unlock the genetic secret behind tuberculosis (TB), which kills more people than AIDS and malaria combined.

‘He welcomed guests as though they were family’

This content was published on Oct 24, 2018

Study finds nanoparticles in over one-quarter of foodstuffs

This content was published on Oct 23, 2018 Nanoparticles were found in over one-quarter of the foodstuffs tested in a pilot study carried out in French-speaking Switzerland.

Rise in illegal medicines confiscated as part of coordinated campaign

This content was published on Oct 23, 2018 As part of a global operation, Swiss authorities confiscated 304 shipments containing illegal medicines - a sharp rise compared to previous years.

Swiss firms attend Saudi forum despite Khashoggi death

This content was published on Oct 23, 2018 Few CEOs, but big Swiss businesses are still very present at Saudi Arabia’s controversial Future Investment Initiative summit this week.

UBS moves back into battle for rich Americans

This content was published on Oct 23, 2018 UBS is putting super-rich Americans at the centre of its new growth strategy, nearly a decade after it was fined by the United States.

UBS repeals China travel warning to employees

This content was published on Oct 23, 2018 Swiss bank UBS has withdrawn a warning to wealth managers against travel to China.

Novartis leukaemia drug approved in Switzerland

This content was published on Oct 22, 2018 Swiss pharmaceutical company Novartis has received approval for its personalised cell therapy Kymriah in Switzerland.

Page 780 of 2840

First … 778 779 780 781 782 … Last

Internal: Archive

Popular Stories

Most Discussed

Internal: Archive

More

Swiss online retailers increasingly hit by fraudsters

More

Rhine Falls water level at historic low

More

Swiss-Brazilian disease research faces uncertain future

More

‘He welcomed guests as though they were family’

More

Study finds nanoparticles in over one-quarter of foodstuffs

More

Rise in illegal medicines confiscated as part of coordinated campaign

More

Swiss firms attend Saudi forum despite Khashoggi death

More

UBS moves back into battle for rich Americans

More

UBS repeals China travel warning to employees

More

Novartis leukaemia drug approved in Switzerland

Popular Stories

Most Discussed